Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours
Por um escritor misterioso
Descrição
Co-administered antibody improves penetration of antibody–dye conjugate into human cancers with implications for antibody–drug conjugates
Full article: Antibody drug conjugates for glioblastoma: current progress towards clinical use
Antibody drug conjugates in brain tumors – new kids on the block?
Antibody–drug conjugates for cancer therapy - The Lancet Oncology
Full article: Antibody drug conjugates for glioblastoma: current progress towards clinical use
Antibody drug conjugates in brain tumors – new kids on the block?
DDC, Free Full-Text
Antibody–drug conjugates for cancer - The Lancet
Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors - ScienceDirect
Antibodies, Free Full-Text
Unlocking the potential of antibody–drug conjugates for cancer therapy
Chemically Defined Antibody– and Small Molecule–Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis
Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions - Chen - 2023 - Cancer Communications - Wiley Online Library
Unlocking the potential of antibody–drug conjugates for cancer therapy
Primary brain tumours in adults - The Lancet
de
por adulto (o preço varia de acordo com o tamanho do grupo)
